These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 343711)

  • 1. [Rifampicin action on the ultrastructure of E. coli cells].
    Zhukov VG; Navashin SM; Zaslavskaia PL
    Antibiotiki; 1978 Feb; 23(2):168-71. PubMed ID: 343711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Action of rifampicin on the ultrastructure of Staphylococcus cells].
    Zhukov VG; Navashin SM; Zaslavaskaia PL
    Antibiotiki; 1977; 22(2):143-5. PubMed ID: 871212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-antibiotic effect induced by an antibiotic combination: influence of mode, sequence and interval of exposure.
    Li RC; Tang MC
    J Antimicrob Chemother; 2004 Nov; 54(5):904-8. PubMed ID: 15375112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of the post-antibiotic effects induced by rifampicin and gentamicin in Escherichia coli.
    Stubbings W; Bostock J; Ingham E; Chopra I
    J Antimicrob Chemother; 2006 Aug; 58(2):444-8. PubMed ID: 16735423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Action of acrylamide on Escherichia coli cells].
    Lusta KA; Starostina NG; Fikhte BA
    Mikrobiologiia; 1982; 51(6):937-40. PubMed ID: 6759886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antagonistic effect of rifampicin on inhibition of the growth of E. coli K12 in the presence of streptomycin].
    Romero E
    G Batteriol Virol Immunol Microbiol; 1973; 66(7-12):211-7. PubMed ID: 4605505
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of in vivo transcription by actinomycin D treatment of ethylenediaminetetraacetic acid-permeabilized Escherichia coli: effects on bacteriophage proliferation.
    Fastame IG; Algranati ID
    Anal Biochem; 1994 Oct; 222(1):163-7. PubMed ID: 7856843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and physiological investigation of rifampicin-resistant RNA polymerase mutants of Escherichia coli K-12. Communication II. Localization of the rifampicin locus on the chromosome map and its fine mapping.
    Alikhanyan SI; Tovmasyan KN
    Sov Genet; 1974 Nov; 9(1):52-6. PubMed ID: 4616345
    [No Abstract]   [Full Text] [Related]  

  • 9. [The role of antioxidant systems in the response of Escherichia coli to acetamidophenol and some antibiotics].
    Smirnova GV; Torkhova OA; Oktiabr'skiĭ ON
    Mikrobiologiia; 2005; 74(2):149-56. PubMed ID: 15938389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in ultrastructure of Escherichia coli under the effect of certain antibiotics].
    Zhukov VG; Navashin SM; Berezina EK
    Antibiotiki; 1976 May; 21(5):429-34. PubMed ID: 799488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibacterial activity of rifampicin against the causative agents of suppurative, septic diseases].
    Samoĭlova LN; Fomina IP; Bodunkova LE
    Antibiotiki; 1977 Jan; 22(1):46-50. PubMed ID: 402885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of a cationic surface-active substance (catamine AB) on the physiological-morphological properties of B. cereus and E. coli].
    Pronin SV; Zhukov VG; Tursunova EM
    Izv Akad Nauk SSSR Biol; 1991; (1):31-42. PubMed ID: 1906901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Growth of Escherichia coli cell culture and frequency of mutation, induced by N-methyl-N'-nitro-N-nitrosoguanidine].
    Goliasnaia NV; Tiurina NA
    Mikrobiologiia; 2000; 69(6):805-9. PubMed ID: 11195581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selective inhibition of ribosomal RNA synthesis by rifampicin in E. coli cells].
    Kliachko EV; Shakulov RS
    Biokhimiia; 1979 Aug; 44(8):1521-3. PubMed ID: 387099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of transduction transmission of R-factors in E. coli by rifampicin].
    Moroz AF; Brodinova NS; Antsiferova NG; Kungurova SA
    Antibiotiki; 1974 Oct; 19(10):901-5. PubMed ID: 4618451
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of RNA/DNA ratio measurements to assess rifampicin-induced growth inhibition of Escherichia coli.
    Ellard GA
    J Antimicrob Chemother; 1991 Sep; 28(3):347-55. PubMed ID: 1720430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal activity of ciprofloxacin upon Escherichia coli and Acinetobacter baumanni.
    Zemelman R; Vejar C; Bello H; Domínguez M; González G
    Rev Latinoam Microbiol; 1992; 34(4):245-8. PubMed ID: 1345113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of rifampicin in experimental animals].
    Koroleva VG; Fomina IP
    Antibiotiki; 1976 Aug; 21(8):722-5. PubMed ID: 999253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect on sublethal terizidon concentration on the mutation rate for streptomycin- and rifampicin resistance in E. coli].
    Urbanczik R
    Arzneimittelforschung; 1974 May; 24(5):723-5. PubMed ID: 4603888
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacology of rifampicin].
    Bykova MA; Solov'ev VN; Berezhinskaia VV; Egorenko GG; Firsov AA
    Antibiotiki; 1977 Jun; 22(6):525-30. PubMed ID: 883799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.